Skip to main content

Hot flushes, sleep and the years around the menopause

Gynaecology

Family practice or menopause clinic, usually between 45 and 55

The first question

Is this the menopause, what is bothering her most, and is there a reason not to offer hormone therapy?

  1. 01

    Confirm the stage

    Over 45 with vasomotor symptoms and changing or absent periods: the diagnosis is clinical and needs no hormone test. Under 45, and especially under 40, test and investigate, because early menopause has consequences.

  2. 02

    Name the symptoms that matter to her

    Vasomotor, sleep, mood, joint aches, genitourinary symptoms, sexual function; use a symptom scale to track them.

  3. 03

    Screen for the mimics and the risks

    Thyroid disease, anaemia, depression, medication effects; breast cancer history and risk, venous thrombosis, cardiovascular disease, liver disease, unexplained bleeding.

  4. 04

    Discuss the options

    Menopausal hormone therapy for those who want it and have no contraindication, transdermal when thrombotic risk is raised, a progestogen whenever the uterus is present; non-hormonal options (cognitive behavioural therapy, SSRI or SNRI, gabapentin, fezolinetant where available); vaginal estrogen for genitourinary symptoms with almost no systemic effect.

  5. 05

    Review

    At three months for symptoms and side effects, then yearly; bleeding on hormone therapy after the first months is investigated as postmenopausal bleeding.

Where it is

Each opens the structure on the 3D pelvis.

History that discriminates

  • Vasomotor symptoms: frequency, night sweats, effect on sleep and work
  • Menstrual pattern over the last year, and any bleeding after 12 months without periods
  • Mood, anxiety, cognition, joint and muscle aches, palpitations
  • Vaginal dryness, dyspareunia, urinary frequency and infections
  • Contraception, which is still needed for a year after the last period over 50 and two years under 50
  • Personal and family history of breast cancer, venous thrombosis, stroke, heart disease, osteoporosis and fracture
  • Smoking, alcohol, weight, exercise and bone risk factors; a hysterectomy or endometriosis in the past
  • What she has tried, what she has read, and what she wants

Examination that discriminates

  • Blood pressure, weight and BMI
  • Breast examination when symptoms or risk warrant it, and screening status
  • Pelvic examination if there is bleeding, pain or genitourinary symptoms: atrophy, an adnexal mass
  • Thyroid gland

Investigations

  • None to diagnose the menopause over 45
  • FSH on two occasions when under 45; under 40, the work-up for premature ovarian insufficiency (karyotype, fragile X premutation, adrenal and thyroid antibodies)
  • Thyroid function, full blood count and ferritin when symptoms could be something else
  • Lipids, glucose and a cardiovascular risk estimate; a fracture risk assessment and bone density where indicated
  • Endometrial assessment for any postmenopausal bleeding or unscheduled bleeding on hormone therapy

The differential

DiagnosisFavoursAgainstUrgency
Perimenopause and menopauseOver 45, vasomotor symptoms, changing then absent periodsUnder 40, a goitre, weight loss, an unexplained bleedroutine
Premature ovarian insufficiencyUnder 40 with irregular or absent periods and raised FSH on two occasionsRegular cycles, normal FSHurgent
Thyroid diseaseHeat intolerance with weight loss, tremor, goitre, or fatigue and weight gain with a raised TSHNormal thyroid functionroutine
Depression or anxiety disorderPersistent low mood, anhedonia, previous episodes; symptoms not tied to hot flushes and sleepMood that tracks the night sweatsroutine
Medication effect or another cause of flushingTamoxifen, aromatase inhibitors, SSRIs, alcohol, carcinoid or mastocytosis in the rare caseA typical menopausal patternroutine
Endometrial pathologyBleeding after 12 months of amenorrhoea, or unscheduled bleeding on hormone therapy beyond the first monthsNo bleedingurgent

Pitfalls this pathway refuses

  • Ordering an FSH to diagnose the menopause in a woman over 45
  • Withholding hormone therapy from a symptomatic woman under 60 without a contraindication because of a general fear of risk
  • Giving estrogen without a progestogen to a woman with a uterus
  • Forgetting contraception in the perimenopause
  • Treating genitourinary symptoms with systemic therapy alone when vaginal estrogen is what works
  • Not investigating bleeding on hormone therapy

Frameworks

  • SOGC: Guideline: menopause and its management (2021).
  • Osteoporosis Canada: Clinical practice guideline for management of osteoporosis and fracture prevention in Canada: 2023 update (2023). Assessment ages and the fracture-risk tools (CAROC, FRAX) follow the Canadian guideline; the module says where other programmes differ.